AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis
Clinical trial NCT03181932 · COMPLETED
Trial details
- NCT number
- NCT03181932
- Sponsor
- Savara Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-20
- Primary completion
- 2020-07-28
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.